source
- Assertio rejects Garda bid, accepts Zydus offer valuing company at $23.50 per shareAssertio Holdings announced it has terminated its pending acquisition by Garda Therapeutics after the board approved a higher offer from another suitor. The new proposal from Zydus Worldwide value…
- Trump administration seeks new FDA commissioner to restore trust, prioritize food policy and accelerate drug approvalsThe Trump administration is moving quickly to name a successor to FDA commissioner Marty Makary, who resigned. Officials say the search will take several weeks and they are looking for a leader wh…